Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06415708
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-03-04
Brief Title:
Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma
Sponsor:
Institute of Hematology Blood Diseases Hospital China
Organization:
Institute of Hematology Blood Diseases Hospital China